CCSynergy: an integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy

Brief Bioinform. 2023 Jan 19;24(1):bbac588. doi: 10.1093/bib/bbac588.

Abstract

Combination therapy is a promising strategy for confronting the complexity of cancer. However, experimental exploration of the vast space of potential drug combinations is costly and unfeasible. Therefore, computational methods for predicting drug synergy are much needed for narrowing down this space, especially when examining new cellular contexts. Here, we thus introduce CCSynergy, a flexible, context aware and integrative deep-learning framework that we have established to unleash the potential of the Chemical Checker extended drug bioactivity profiles for the purpose of drug synergy prediction. We have shown that CCSynergy enables predictions of superior accuracy, remarkable robustness and improved context generalizability as compared to the state-of-the-art methods in the field. Having established the potential of CCSynergy for generating experimentally validated predictions, we next exhaustively explored the untested drug combination space. This resulted in a compendium of potentially synergistic drug combinations on hundreds of cancer cell lines, which can guide future experimental screens.

Keywords: Chemical Checker; cancer cell lines; deep learning; drug synergy; untested drug combination space.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Cell Line, Tumor
  • Computational Biology / methods
  • Deep Learning*
  • Drug Combinations
  • Drug Synergism

Substances

  • Antineoplastic Agents
  • Drug Combinations